Latest Interleukin 1 Stories
Cedars-Sinai researchers have unlocked the mystery of how an inflammatory molecule is produced in the body, a discovery they say could lead to advances in the treatment of rheumatoid arthritis, Type 2 diabetes and numerous other chronic diseases that affect tens of millions of people.
By analyzing complex interactions of the immune system in an animal study, pediatric researchers have found potential tools for controlling a life-threatening condition called a cytokine storm that may strike children who have juvenile arthritis and other autoimmune diseases.
Up-regulation of certain cytokines and chemokines (signaling molecules involved in the functioning of the immune system) can predict the development of rheumatoid arthritis (RA) three years before the onset of symptoms, according to the results of a new study presented today at EULAR 2009, the Annual Congress of the European League Against Rheumatism in Copenhagen, Denmark.
Three immune system researchers were awarded the nation's richest prize in medicine and biomedical research on Friday for their work that led to new treatments for rheumatoid arthritis and diabetes.
U.S. scientists say they have taken the first step toward developing a pharmaceutical medication to treat smallpox and the emerging human monkeypox. A major breakthrough by Oklahoma State University Assistant Professor Junpeng Deng and Ph.D.
- A person in a secondary role, specifically the second most important character (after the protagonist).